Orbimed Advisors LLC

Director at SION; 10% owner at ELVN; 10% owner at PMVP, and 29 more

Sold, on record
$647M
Dollars the filings state
Form 4 sales
75
Latest Jun 30, 2026
Form 144 notices
27
Proposed sales
Companies
32
Filed as an executive or holder

Companies

Sales by reason

5
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale SIONRoutine
    Nov 26 2025

    Sold 108,073 shares at $44.55 ($4.8M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 2.9% of holdings ($165M position)3.6M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale SIONRoutine
    Apr 16 +141 days

    Sold 510,583 shares at $44.94 ($22.9M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 14.5% of holdings ($159M position)3M shares leftFiling

  3. 3 Form 4 sale SIONRoutine
    Apr 18 +2 days

    Sold 55,345 shares at $44.67 ($2.5M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 1.8% of holdings ($135M position)3M shares leftFiling

  4. 4 Form 4 sale SIONRoutine
    May 11 +23 days

    Sold 292,952 shares at $45.62 ($13.4M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 9.9% of holdings ($135M position)2.7M shares left2.7x usual sizeFiling

  5. 5 Form 4 sale SIONRoutine
    May 27 +16 days

    Sold 101 shares at $44.49 ($4k)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 0% of holdings ($119M position)2.7M shares left0x usual sizeFiling

  6. 6 Form 4 sale ELVNNo plan
    Jun 15 +19 days

    Sold 281,408 shares at $45.02 ($12.7M)

    Orbimed Advisors LLC, 10% owner

    No 10b5-1 planSold 3.7% of holdings ($345M position)7.4M shares leftFirst sale on recordFiling

  7. 7 Form 4 sale ELVNNo plan
    Jun 22 +7 days

    Sold 860,123 shares at $45.36 ($39M)

    Orbimed Advisors LLC, 10% owner

    No 10b5-1 planSold 11.6% of holdings ($336M position)6.6M shares leftFiling

  8. 8 Form 4 sale SIONRoutine
    Jun 30 +8 days

    Sold 115,844 shares at $45.50 ($5.3M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 4.3% of holdings ($122M position)2.6M shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (102)

Form 144 notices and Form 4 sales by Orbimed Advisors LLC
Source
Jun 30, 2026SIONDirectorForm 4 sale115,844$5.3M4.3%RoutineSEC
Jun 22, 2026ELVN10% ownerForm 4 sale860,123$39M11.6%No planSEC
Jun 15, 2026ELVN10% ownerForm 4 sale281,408$12.7M3.7%No planSEC
May 27, 2026SIONDirectorForm 4 sale101$4k0.0%RoutineSEC
May 11, 2026SIONDirectorForm 4 sale292,952$13.4M9.9%RoutineSEC
Apr 18, 2026SIONDirectorForm 4 sale55,345$2.5M1.8%RoutineSEC
Apr 16, 2026SIONDirectorForm 4 sale510,583$22.9M14.5%RoutineSEC
Nov 26, 2025SIONDirectorForm 4 sale108,073$4.8M2.9%RoutineSEC
Sep 10, 2025PMVP10% ownerForm 4 sale500,000$900k7.7%No planSEC
Jun 27, 2025CRVSDirector, 10% ownerForm 4 sale1.2M$4.9M14.1%No planSEC
Jun 26, 2025PASG10% ownerForm 4 sale583,657$197k8.8%UnusualSEC
May 14, 2025NPCE10% ownerForm 4 sale168,136$2.7M4.9%UnusualSEC
Apr 24, 2025PASG10% ownerForm 4 sale235,572$79k3.4%UnusualSEC
Mar 24, 2025IRONDirectorForm 4 sale5,738$310k3.0%No planSEC
Jan 14, 2025PASG10% ownerForm 4 sale223,219$142k3.1%No planSEC
Dec 11, 2024PASG10% ownerForm 4 sale62,276$52k0.8%No planSEC
Dec 6, 2024PASG10% ownerForm 4 sale97,103$77k1.2%No planSEC
Dec 4, 2024PASGStockholderForm 144 notice3M$2.7MNoticeSEC
Sep 19, 2024PASG10% ownerForm 4 sale39,300$28k0.5%No planSEC
Jul 2, 2024TELA10% ownerForm 4 sale428,300$2M15.1%No planSEC
May 3, 2024NPCE10% ownerForm 4 sale29,206$409k0.9%No planSEC
Apr 24, 2024NPCE10% ownerForm 4 sale1,781$25k0.1%No planSEC
Apr 23, 2024NPCE10% ownerForm 4 sale64,653$913k1.8%No planSEC
Dec 12, 2023IRONShareholderForm 144 notice121,840$7.4MNoticeSEC
Dec 12, 2023IRONShareholderForm 144 notice315,000$19.2MNoticeSEC
Dec 12, 2023IRONShareholderForm 144 notice487,360$29.7MNoticeSEC
Nov 22, 2023PMVPShareholderForm 144 notice87,786$198kNoticeSEC
Oct 2, 2023DMRAShareholderForm 144 notice37,675$27kNoticeSEC
Oct 2, 2023DMRAShareholderForm 144 notice585,274$421kNoticeSEC
Oct 2, 2023NPCEShareholderForm 144 notice288,100$2.6MNoticeSEC
Aug 30, 2023DMRAShareholderForm 144 notice78,659$46kNoticeSEC
Aug 30, 2023DMRAShareholderForm 144 notice1.2M$709kNoticeSEC
Aug 21, 2023DMRAShareholderForm 144 notice1.5M$932kNoticeSEC
Aug 21, 2023DMRAShareholderForm 144 notice75,473$57kNoticeSEC
Aug 15, 2023DMRAShareholderForm 144 notice1.2M$880kNoticeSEC
Aug 15, 2023DMRAShareholderForm 144 notice75,473$57kNoticeSEC
Jul 31, 2023DMRAShareholderForm 144 notice930,717$2.8MNoticeSEC
Jul 31, 2023DMRAShareholderForm 144 notice162,153$490kNoticeSEC
Jul 25, 2023DMRAShareholderForm 144 notice26,700$63kNoticeSEC
Jul 25, 2023DMRAShareholderForm 144 notice7,800$18kNoticeSEC
Jul 13, 2023DMRAShareholderForm 144 notice132,100$337kNoticeSEC
Jul 13, 2023DMRAShareholderForm 144 notice9,800$25kNoticeSEC
Jun 15, 2023Gracell Biotechnologies Inc.ShareholderForm 144 notice305,748$1.8MNoticeSEC
May 15, 2023VRNADirectorForm 4 sale482,913$9.9M11.3%No planSEC
May 11, 2023VRNAShareholderForm 144 notice2.6M$60.4MNoticeSEC
Apr 21, 2023TELA10% ownerForm 4 sale192,000$1.8M6.3%No planSEC
Apr 19, 2023TELAShareholderForm 144 notice192,000$2MNoticeSEC
Apr 17, 2023DMRA10% ownerForm 4 sale68,481$128k2.8%No planSEC
Apr 10, 2023DMRAShareholderForm 144 notice1,686$3kNoticeSEC
Apr 10, 2023DMRAShareholderForm 144 notice22,638$43kNoticeSEC
Apr 5, 2023DMRAShareholderForm 144 notice109,532$245kNoticeSEC
Apr 5, 2023DMRAShareholderForm 144 notice8,143$18kNoticeSEC
Nov 25, 2022Tricida, Inc.Director, 10% ownerForm 4 sale10.3M$2.2M100.0%UnusualSEC
Aug 9, 2022SWTX10% ownerForm 4 sale274,568$10.5M4.6%UnusualSEC
Sep 2, 2021Repare Therapeutics Inc.DirectorForm 4 sale37,864$1.3M28.2%UnusualSEC
Aug 18, 2021Repare Therapeutics Inc.DirectorForm 4 sale20,328$693k17.1%Plan not statedSEC
Jul 1, 2021SWTX10% ownerForm 4 sale15,959$1.4M0.3%Plan not statedSEC
Jun 25, 2021SWTX10% ownerForm 4 sale56,634$4.8M0.9%Plan not statedSEC
Jun 10, 2021SWTX10% ownerForm 4 sale30,852$2.6M0.5%Plan not statedSEC
Jun 9, 2021SWTX10% ownerForm 4 sale48,053$4.1M0.8%Plan not statedSEC
Mar 30, 2021ORICDirectorForm 4 sale103,424$2.4M4.5%Plan not statedSEC
Mar 26, 2021ORICDirectorForm 4 sale112,298$2.8M4.6%Plan not statedSEC
Mar 15, 2021ORICDirectorForm 4 sale238,282$7.3M8.6%Plan not statedSEC
Aug 14, 2020INSPDirectorForm 4 sale92,187$10M40.0%UnusualSEC
Aug 11, 2020INSPDirectorForm 4 sale116,570$12.3M33.6%UnusualSEC
Apr 16, 2020ALEC10% ownerForm 4 sale85,414$2M4.3%Plan not statedSEC
Apr 9, 2020ALEC10% ownerForm 4 sale379,885$9M16.5%Plan not statedSEC
Mar 31, 2020ALEC10% ownerForm 4 sale250,000$6.1M11.0%Plan not statedSEC
Mar 25, 2020ALEC10% ownerForm 4 sale138,653$3.4M6.2%Plan not statedSEC
Mar 6, 2020INSPDirectorForm 4 sale500,000$41.8M59.0%UnusualSEC
Mar 2, 2020ALEC10% ownerForm 4 sale1.9M$48.7M100.0%UnusualSEC
Dec 26, 2019ALEC10% ownerForm 4 sale519,385$10.2M92.8%UnusualSEC
Dec 17, 2019ALEC10% ownerForm 4 sale954,100$17.7M90.7%UnusualSEC
Dec 11, 2019Tricida, Inc.Director, 10% ownerForm 4 sale1.5M$60M13.5%Plan not statedSEC
Nov 27, 2019INSPDirectorForm 4 sale124,000$8.8M8.4%Plan not statedSEC
Mar 8, 2019INSPDirectorForm 4 sale358,449$20.5M19.6%Plan not statedSEC
Aug 20, 2018ViewRay, Inc.10% ownerForm 4 sale521,607$5.2M88.2%UnusualSEC
Apr 30, 2018PVLA10% ownerForm 4 sale1M$6.3M96.3%UnusualSEC
Mar 29, 2018ADAPYDirectorForm 4 sale1M$12.1M17.0%Plan not statedSEC
Mar 6, 2018GKOSDirectorForm 4 sale836,500$26.8M100.0%UnusualSEC
Mar 6, 2018Audentes Therapeutics, Inc.10% ownerForm 4 sale433,210$15.2M10.5%Plan not statedSEC
Aug 22, 2017Roka BioScience, Inc.10% ownerForm 4 sale75,276$114k90.7%UnusualSEC
Aug 12, 2016GKOSDirectorForm 4 sale292,938$9.9M93.4%UnusualSEC
Aug 10, 2016Loxo Oncology, Inc.DirectorForm 4 sale447,857$12.1M20.6%Plan not statedSEC
Nov 30, 2015Otonomy, Inc.DirectorForm 4 sale67,106$1.9M3.5%Plan not statedSEC
Mar 26, 2015INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale157,200$45.1M12.3%Plan not statedSEC
Aug 26, 2014INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale111,258$33.2M7.0%Plan not statedSEC
Oct 21, 2013INTERCEPT PHARMACEUTICALS INCDirectorForm 4 sale40,088$2.5M2.3%Plan not statedSEC
Jul 13, 2012COMPLETE GENOMICS INC10% ownerForm 4 sale1.2M$3.3M97.7%UnusualSEC
Jun 19, 2012AMRNDirectorForm 4 sale617,100$8M98.2%UnusualSEC
Mar 22, 2012Anthera Pharmaceuticals IncDirectorForm 4 sale1.5M$3.8M54.7%UnusualSEC
Dec 13, 2011Anthera Pharmaceuticals IncDirectorForm 4 sale56,200$375k1.9%Plan not statedSEC
Mar 28, 2011AMRNDirectorForm 4 sale173,000$1.3M73.8%UnusualSEC
Mar 21, 2011AMRNDirectorForm 4 sale77,000$543k55.0%UnusualSEC
Sep 15, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale54,000$876k1.4%Plan not statedSEC
Sep 14, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale389,900$6.5M9.4%Plan not statedSEC
Aug 18, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale500,200$8.5M10.6%Plan not statedSEC
Aug 4, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale317,700$5.2M6.3%Plan not statedSEC
Jul 28, 2010NxStage Medical, Inc.Director, 10% ownerForm 4 sale700,556$11.8M12.3%Plan not statedSEC
Jun 10, 2009Biodel IncDirectorForm 4 sale26,988$141k1.8%Plan not statedSEC
May 22, 2009ARYx Therapeutics, Inc.10% ownerForm 4 sale2M$8M59.9%UnusualSEC
Feb 12, 2008Biodel IncDirector, 10% ownerForm 4 sale154,000$2.2M7.8%Plan not statedSEC